Zileuton (Prasco, LLC)
Welcome to the PulseAid listing for the Zileuton drug offered from Prasco, LLC. This 5-Lipoxygenase Inhibitor [EPC],5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Prasco, LLC |
NON-PROPRIETARY NAME: | Zileuton |
SUBSTANCE NAME: | ZILEUTON |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | 5-Lipoxygenase Inhibitor [EPC],5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2017-03-29 |
END MARKETING DATE: | 0000-00-00 |
Zileuton HUMAN PRESCRIPTION DRUG Details:
Item Description | Zileuton from Prasco, LLC |
LABELER NAME: | Prasco, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 600(mg/1) |
START MARKETING DATE: | 2017-03-29 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66993-485_cac42cc3-792c-4b76-a398-c4961fea3018 |
PRODUCT NDC: | 66993-485 |
APPLICATION NUMBER: | NDA022052 |
Other ZILEUTON Pharmaceutical Manufacturers / Labelers: